Skip to content
MarketScale
‹ Back to Industries

Sciences

The increasing utility of machine learning in astrophysical research

Hunter Gabbard, a PHD candidate at the University of Glasgow and the LIGO scientific collaboration, spoke to Sean Heath for our Science podcast in a first of three part series discussing different elements of machine learning. In today’s episode, we discuss the relationship between human and machine learning and how these machines can even help…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Zach Werblo ·
Share
The increasing utility of machine learning in astrophysical research

Key takeaways

01

Hunter Gabbard, a PHD candidate at the University of Glasgow and the LIGO scientific collaboration, spoke to Sean Heath for our Science podcast in a first of three part series discussing different elements of machine learning.

02

In today’s episode, we discuss the relationship between human and machine learning and how these machines can even help…

Hunter Gabbard, a PHD candidate at the University of Glasgow and the LIGO scientific collaboration, spoke to Sean Heath for our Science podcast in a first of three part series discussing different elements of machine learning. In today’s episode, we discuss the relationship between human and machine learning and how these machines can even help us better understand some of the universe’s biggest mysteries.

Sean Heath: So today I want to start off with just the basic concept of human learning. Talk to me about how something goes from an idea, to research, to somewhat of established knowledge.

Hunter Gabbard: I think to first understand that, you must first ask the question ‘how do humans learn’. When you try to make a machine think the same way as a human, there are many problems that arise. One of the biggest is having to give the machine a problem to solve. Whereas with a human, you’re not going to be told what questions to answer. With a machine you have to tell it what to solve. We haven’t gotten to the point at least with machine learning to have machines establish questions on their own. We’re able to ask those questions, yes, but the you have to come up with the problem for the machine to solve.

If someone were to figure that out, they’d be a very rich person

SH: As you mentioned one person gets a question, they test that question. Then they report those results & the process is repeated until there’s a large gathering of data that then can be looked at observed, and becomes established knowledge. Machine learning can take that process and accelerate it exponentially, but one thing machine learning can’t do that humans do naturally is look for shortcuts. Machines don’t take the initiative to find shortcuts when solving a problem, do they?

HG: It depends on how you define shortcuts. So with a machine learning algorithm, the reason they’re so much faster is that most of the power it takes to try and solve a problem on a normal program or even a normal human brain, is all done in the very beginning after training itself over and over again on some problem you’re trying to get it solved. Once it’s trained on that specific problem you then just say ‘ok I’ll feed it some new stuff it’s never seen before’, that’s when it will produce an answer. Once you’ve trained the machine on that one problem it’s sort of set in its ways you don’t have to adjust anything. You sort of set it up and it’s on it’s way.

SH: So it’s basically a constant series of layers of “if-then” statements?

HG: Yeah, it’s basically a bunch of filter to some.

And this specific variant of Machine Learning I’m referring to is deep learning. There are all different variants of machine learning out there. There are some that are simple others that are more complex like generative adversarial networks.

How I like to think of them is sort of like a cops and counterfeiters game. You have two of these AI competing against the other. One neural network is the counterfeiter the other is the cop.

The counterfeiter network is trying to make fake Picasso’s against which the cop network is trying to determine its authenticity. All you’re doing is feeding noise to these neural networks and as a result something pops out. What the cop network does is compare the AI product to real Picasso paintings and figure out which is which.

If the cop successfully figures it out, it is rewarded. If it is fooled, it’s penalized. The counterfeiter network is also rewarded if it fools the cop.

I think that’s the best analogy, it’s sort of a Darwinian adversarial evolution type deal. It’s very interesting and they’re very powerful and can make some weird things. Google used this and produced these “dream-like” images from the data it was being fed. It’s a very hot topic right now

SH:One of the things you’re doing at the LIGOSC is you’re applying those principles and processes into more in-depth study into black holes. I think with the recent passing of Stephen hawking it’s very appropriate to talk about black holes today. How is AI opening up avenues from study for you in regards to black holes?

HG: What we do at Ligo is look at gravitational waves, which were originally predicted by Einstein through his general theory of relativity. You can get these waves from very violent events like the merger of two neutron stars or, in this instance, the merger of two black holes. When you get that merger, you get these ripples in space-time that travels out after these events and a lot of energy is dispersed.

Some of that energy is in the form of gravitational waves which eventually hits us. We measure these waves using essentially a very fine ruler that’s able to measure the bending and squeezing of space-time. Now, the signal is very very tiny.

To measure the signal would be liken standing on earth and trying to watch a star wiggle by the width of a human hair. So because these signals are so small they’re buried in the noise produced by the detectors, so it’s a data analysis problem at that point. Right now, we have something called match template filtering.

We construct different templates of gravitational wave wave forms and produce a template bank. Once we see we’ve found a signal, we run this against the cache of data and the best match gives you back the signal.

It takes slot of time to do this and could be sped up by quite a lot. One way of doing this is through deep learning. We recently published a paper discussing deep learning, a form of AI that uses multiple layers and neurons, and feeding it the raw time series from the detector and receiving and instant yes/no answer as to whether it’s a signal or noise. There’s a lot of potential in this field in applying it towards the search for gravitational waves.

SH: I just had one more question involving the growing collaboration between the physical sciences and computer scientists. It seems like such a natural fit— do you find that we’re moving more towards a spirit of collaboration and cooperation?

HG: Yeah I agree. It would be nice to have more collaboration between the two groups. Right now with machine learning applications in gravitation wave astronomy we are using techniques that have been around for a while. What I’m doing now is using those generative adversarial networks, and this is an idea proposed by Ian Goodfellow a researcher at Google Brain in 2014, so it’s a bit of old news to people in the community along with other techniques like deep learning. I think it’d be good to have more collaboration between the two because that way you can make these discoveries that much more quickly. 

For the latest news, videos, and podcasts in the Sciences Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – ScienceMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

About the author

New to MarketScale?

MarketScale is the platform Sciences companies use to turn their own experts into content like this. Want the short overview?

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

The pharmaceutical industry is facing a significant challenge as over $300 billion in branded pharmaceutical revenue is set to lose patent protection by 2030. This revenue gap is driving the largest merger and acquisition cycle seen in a decade, with companies seeking external growth through acquisitions. This shift is impacting the entire life sciences supply chain, prompting strategic changes across the industry.

  • 01Over $300 billion in pharmaceutical revenue is at risk due to patent expirations by 2030.
  • 02Big Pharma is engaging in an aggressive cycle of mergers and acquisitions.
  • 03The acquisitions are reshaping the life sciences supply chain.

Jun 29, 2026

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I clinical study of an oral solid dose formulation designed using AI, cleared by the UK's MHRA and conducted at the company's UK facility. The trial—built on machine learning algorithms from partner Intrepid Labs and Quotient's Translational Pharmaceutics platform—aims to validate AI as a direct contributor to formulation design rather than just an upstream analytical tool. Benchling characterizes the broader moment as biotech entering a "builder phase," in which leading organizations embed AI capability at the bench level rather than running isolated pilots.

  • 01Quotient Sciences has dosed healthy volunteers in a Phase I study it describes as the first clinical evaluation of an AI-designed oral formulation, following approval from the UK's MHRA.
  • 02The formulation was developed using advanced machine learning algorithms from Intrepid Labs, integrated with Quotient Sciences' Translational Pharmaceutics platform.
  • 03Benchling identifies a sector-wide shift toward embedding AI capability directly at the bench, moving beyond isolated pilots to structural adoption across biotech R&D.

Jun 17, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

ZW
Zach Werblo